Madam Chair, according to industry documents reviewed by Reuters, the pharmaceutical industry has made a last-ditch offer to the Government to Canada to spend $1 billion over 10 years to block the coming into force of the amended patented medicines regulations set to go into force on January 1.
According to an industry estimate, the regulations would reduce drug companies' revenue by $20 billion over 10 years; $6 billion by the estimate of the PMPRB.
Will the minister confirm that the Government of Canada will refuse this blatant attempt to buy regulatory benefits from the drug industry?